Clinical Trials Browser

Phase 2 × 1-phenyl-3,3-dimethyltriazene × 90 days × Clear all

NCT05020912 2026-06-01

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

Phase 2 Active not recruiting

Carcinoma, Basal Cell